Instead of total abundance, more recent data demonstrate that changes in sulfated GAGs in AD brain tissue are associated with altered glycan-protein binding with extracellular factors, including decreased interactions with FGF2 and VEGF and increased binding to Tau (Huynh et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.